Sandro Belvedere
Corporate Officer/Principal at ARMGO Pharma, Inc.
Profile
Sandro Belvedere's current job is Vice President-Chemistry at ARMGO Pharma, Inc. He previously worked as a Research Leader & Senior Scientist at GSK Plc and as a Research Scientist at Aton Pharma, Inc. He holds a graduate degree from the University of Rochester, an undergraduate degree from The American University of Rome, and a doctorate degree from The Trustees of Columbia University in The City of New York.
Sandro Belvedere active positions
| Companies | Position | Start |
|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | 2005-12-31 |
Former positions of Sandro Belvedere
| Companies | Position | End |
|---|---|---|
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Training of Sandro Belvedere
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Rochester Christian University | Graduate Degree |
| The American University of Rome | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 2 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
- Stock Market
- Insiders
- Sandro Belvedere
